InsiderTrades

Form 4 for BIO BIO-RAD LABORATORIES, INC.

Accepted 2024-04-30 00:00:00 ET · period of report 2024-04-29 · accession 0001062993-24-009082 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-04-30 2024-04-29 BIO Last Andrew J. EVP, COO F - Tax $277.11 -357 5,720 -6% -$98.9K
D 2024-04-30 2024-04-29 BIO Last Andrew J. EVP, COO M - OptEx $0.00 +1,000 6,077 +20% $0
D 2024-04-30 2024-04-29 BIO Last Andrew J. EVP, COO M - OptEx $0.00 -1,000 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Bio-Rad A Common Stock 2024-04-29 F D 357 $277.11 5,719.89 D — —
2 Common Bio-Rad A Common Stock 2024-04-29 M A 1,000 $0.00 6,076.89 D — — (F1) Shares of Class A common stock acquired on the vesting of restricted stock units. (F2) Includes 9.7660 and 27.5220 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 09/30/2023 and 03/31/2024, respectively.
3 Derivative Restricted Stock Units 2024-04-29 M D 1,000 $0.00 0 D $0.00 · — to — 1,000 Bio-Rad A Common Stock (F3) Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. (F4) On April 29, 2019, the reporting person was granted 5,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date.